The Partnership to Reduce Cancer in Rhode Island Presents

2011 Rhode Island Cancer Summit

Personalized Medicine - The Future of Cancer Care

Thursday, June 16, 2011

7:30AM to 3:00PM

The Crowne Plaza

801 Greenwich Ave.

Warwick, RI

CEUs Have Been Approved for:

RN, Social Workers and Cancer Registrars*

DRAFT AGENDA (Agenda Subject to Change)

7:30-8:15AM- Exhibits/Registration

8:15-9:00AM - Opening Remarks -

Linda Dziobek, Chair, The Partnership to Reduce Cancer in Rhode Island

The Burden of Cancer in Rhode Island - John Fulton, PhD, RI Cancer Registry, RI Department of Health

Presentation of Survey Data:  What this Means to You - Brian Denton, Treasurer, The Partnership to Reduce Cancer in Rhode Island

9:00-10:00AM - Keynote Address:  Personalized Medicine

William Li, MD, President and Medical Director, The Angiogenesis Foundation

10:00-10:15AM - Break

10:15-10:30AM - Question and Answer Session

10:30-10:45AM - Panel Discussion:  The Rhode Island Perspective on Personalized Medicine

Discussions featuring the foremost professionals from the provider, patient, payer, industry, and business realms of cancer care.

Joe Dziobek, President/CEO, Fellowship Health Resources

Dr. Gus Manocchia, Vice President and Chief Medical Officer, Blue Cross & Blue Shield of RI

Ashley Stuckey, MD, Gynecologic Oncologist/Breast Surgeon, Women & Infants Hospital/Kent Breast Health Center

Carlton R. Johnson, Prostate Cancer Survivor, Portsmouth, RI

11:45AM-12:00PM - Question and Answer Session

 12:00-12:45PM - Lunch

"Meet the Experts" - Poster Abstracts

Presentation of 3rd Annual Spirit Award

1:00-3:00PM - Break-Out Sessions

Break-Out Sessions will allow particpants to join a discussion on cancer-related topics of interest.  The goal of each session is to enhance learning through interactive dialogue lead by subject experts.  Participants will be able to select 2 out of the 3 45-minute sessions offered.

Bridges From Cure to Healthy Living: Advancing Practice in the CHAMPS Survivorship Clinic
Facilitated By:  Cindy Schwartz, MD; June Bjerregaard, MSN, FNP; Fred Barbosa, MSW,
Hasbro Children’s Hospital
I.  Overview of pediatric and adolescent cancer survivorship care. II.  Medical care of pediatric survivors from chart review and risk assessment to evaluation, health management, surveillance, referral, personalized health promotion and education.  III.  Psychosocial assessment, typical challenges, accessing support systems and interfacing with the community. 

Understanding Your Cancer Risk: Why Should I Consider Cancer Genetic Counseling and Testing?
Facilitated By:  Jessica Kent Laprise, MS, CGC, Cancer Genetic Counselor, and Jennifer Scalia Wilbur, MS, Clnical Program Manager, Cancer Risk Assessment & Prevention Program, Women & Infants Hospital Program in Women's Oncology
This session will explore the process of hereditary cancer risk assessment including risk factors, genetic counseling, and testing.  Case examples of families at risk for hereditary breast, ovarian, and colon cancers will be used to illustrate and answer some of the complex questions often asked by individuals contemplating or undergoing genetic testing.

Wellness: How to  Use our Social Connections to Improve Our Health 
Facilitated By:  Colin Murphy, RN, MBA, Executive Director, Shape Up RI
Those around us influence our behavior in significant and predictable ways. Learn how to make wellness contagious in your network, your workplace and your community. 

To learn more about The Partnership, please visit our website:

http://www.cancercoalition.ri.gov

* Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 5.0 continuing education contact hours through the California Board of Registered Nursing and Provider Number 1105 is approved as a provider as well as for social work continuing education by the Association of Social Work Boards (ASWB) (www.aswb.org) Approved Continuing Education Program (ACE). Approval Period: 12/2011-12/2014. 

Approval for Cancer Registrar’s continuing education hours was reviewed by the National Cancer Registrars Association’s Program Recognition Committee and was found to support 6 CE hours. This program has been assigned the event number 2011-063.